The annual increase reached 1123%! Chinese and American pharmaceutical companies collaborate to defeat 'global pharmaceutical king' CEO, bluntly stating 'we are on the right side'
藏獒47
发表于 2024-9-21 22:40:22
1219
0
0
In this week's US stock market, a stock called Summit Pharmaceuticals (SMMT) emerged as a rising force. In addition to its own 160% surge, it also pulled up biotech companies such as BioNTech and Instil Bio. Since the beginning of the year, Summit Pharmaceuticals has risen from less than $3 to $31.93 at the end of this week, with a staggering increase of 1123.37%, and its market value has risen to $23.1 billion. Behind this, in addition to the common benefits of new drug development, there is also a story of China US cooperation.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Sanofi's star drug was approved on the same day in China and the United States, marking the first treatment plan for this common lung disease
- Expected to increase by another 5% by the end of the year! Goldman Sachs raises target price for S&P 500 index for third time this year
- Miniso collaborates with Meituan to accelerate the layout of Lightning Warehouse, which will launch 800 super stores within the year
- 800 24-hour super stores will be launched within the year, and Miniso and Meituan have reached a deep strategic cooperation
- What did the China US Economic Working Group discuss? Latest disclosure!
- A week that goes down in history! Global funds focus on China and the United States, with three major macro events about to take place
- Forbidden within 5 years! The US Department of Justice has officially requested Google to divest Chrome and terminate its exclusive agreement with Samsung and Apple
- NIO will build 9 vertical and 9 horizontal high-speed battery swapping networks within the next year
- Premium 26%, Turnover 647%! During the year, the popularity of new funds soared, and multiple ETFs showed high premiums, resulting in a significant increase in the size of the remaining funds
- He Xiaopeng releases internal letter at the beginning of the year: Price war meeting will start from January